Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Rocket Pharmaceuticalsrocketpharma.com · Low evidenceRocket Pharmaceuticals develops gene therapies for rare genetic diseases using lentiviral and adeno-associated viral platforms. The company focuses on curing bone marrow-derived and cardiovascular conditions with high unmet medical needs.
Parse Score